Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mami Nishie"'
Autor:
Takeshi Zendo, Kenji Sonomoto, Jun-ichi Nagao, Mami Nishie, Jiro Nakayama, Chinatsu Shimafuji, Megumi Noguchi, Kouki Shioya
Publikováno v:
Journal of Bioscience and Bioengineering. 120:624-629
Lantibiotics are antibacterial peptides containing unique thioether cross-links termed lanthionine and methyllanthionine. NukM, the modifying enzyme of nukacin ISK-1, which is produced by Staphylococcus warneri ISK-1, catalyzes the dehydration of spe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a5964b26fa11f22e110481c150648ab
https://doi.org/10.1016/j.jbiosc.2015.03.020
https://doi.org/10.1016/j.jbiosc.2015.03.020
Publikováno v:
Applied microbiology and biotechnology. 102(2)
Lantibiotic nukacin ISK-1 is produced by Staphylococcus warneri ISK-1. The dual functional transporter NukT, an ABC transporter maturation and secretion protein, contributes to cleavage of the leader peptide from the prepeptide (modified NukA) and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe1c2ca294bcf148681c470d4b2db07
https://pubmed.ncbi.nlm.nih.gov/29167920
https://pubmed.ncbi.nlm.nih.gov/29167920
Autor:
Daisuke Kohda, Mami Nishie, Hans-Georg Sahl, Jiro Nakayama, Jun Ichi Nagao, Kenji Sonomoto, Sandro Keller, Takeshi Zendo, Mohammad Riazul Islam
Publikováno v:
Journal of the American Chemical Society. 134:3687-3690
Ring A of nukacin ISK-1, which is also present in different type-A(II) lantibiotics, resembles a lipid II-binding motif (TxS/TxD/EC, x denotes undefined residues) similar to that present in mersacidin (type-B lantibiotics), which suggests that nukaci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b95588091cbeceb8c7ec7cd970bb589
https://doi.org/10.1021/ja300007h
https://doi.org/10.1021/ja300007h
Antibacterial Peptides 'Bacteriocins': An Overview of Their Diverse Characteristics and Applications
Publikováno v:
Biocontrol Science. 17:1-16
Bacteriocins are ribosomally synthesized antibacterial peptides produced by bacteria that inhibit the growth of similar or closely related bacterial strains. A number of bacteriocins from a wide variety of bacteria have been discovered, and their div
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033e85a41ae388bfc8b6934b768f779f
https://doi.org/10.4265/bio.17.1
https://doi.org/10.4265/bio.17.1
Autor:
Mami Nishie, Tijo Varghese Puramattathu, Ken Ichi Okuda, Jun-ichi Nagao, Takeshi Zendo, Sae Yanagihara, Mohammad Riazul Islam, Kenji Sonomoto, Jiro Nakayama
Publikováno v:
Applied Microbiology and Biotechnology. 93:671-678
Nukacin D13E (D13E) is a variant of type-A(II) lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. D13E exhibited a twofold higher specific antimicrobial activity than nukacin ISK-1 against a number of Gram-positive bacteria. We previ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b98c53ee0ae3ce4a6217ef341a87406
https://doi.org/10.1007/s00253-011-3563-1
https://doi.org/10.1007/s00253-011-3563-1
Autor:
Jun-ichi Nagao, Takeshi Zendo, Jiro Nakayama, Mohammad Riazul Islam, Mami Nishie, Kouki Shioya, Kenji Sonomoto, Hiroyuki Jikuya
Publikováno v:
Molecular Microbiology. 72:1438-1447
Summary Nukacin ISK-1, a type-A(II) lantibiotic, comprises 27 amino acids with a distinct linear N-terminal and a globular C-terminal region. To identify the positional importance or redundancy of individual residues responsible for nukacin ISK-1 ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aefe5312f2b4bd04a498d93d7baae83
https://doi.org/10.1111/j.1365-2958.2009.06733.x
https://doi.org/10.1111/j.1365-2958.2009.06733.x
Publikováno v:
The Journal of biological chemistry. 286(13)
Lantibiotics are ribosomally synthesized and post-translationally modified peptide antibiotics that contain unusual amino acids such as dehydro and lanthionine residues. Nukacin ISK-1 is a class II lantibiotic, whose precursor peptide (NukA) is modif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837c1baa455182aa34f16f03b3440ee8
https://pubmed.ncbi.nlm.nih.gov/21303905
https://pubmed.ncbi.nlm.nih.gov/21303905
Publikováno v:
Current pharmaceutical biotechnology. 12(8)
Lantibiotics are ribosomally synthesized, post-translationally modified, peptide antibiotics containing unusual amino acids such as dehydrated amino acids and lanthionine. These unusual amino acids impose conformational constraints on the peptide and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71fa1e9ee7cb47d6de0836105e24a14
https://pubmed.ncbi.nlm.nih.gov/21470152
https://pubmed.ncbi.nlm.nih.gov/21470152
Publikováno v:
Journal of bioscience and bioengineering. 108(6)
NukT, a possible ABC transporter maturation and secretion (AMS) protein, may contribute to the cleavage of the leader peptide of NukA, which is the prepeptide of the lantibiotic nukacin ISK-1, and to nukacin ISK-1 transport. In this study, we reconst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d194152b6a8442f2f20fad4f53157989
https://pubmed.ncbi.nlm.nih.gov/19914576
https://pubmed.ncbi.nlm.nih.gov/19914576